Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1945525rdf:typepubmed:Citationlld:pubmed
pubmed-article:1945525lifeskim:mentionsumls-concept:C0026794lld:lifeskim
pubmed-article:1945525lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1945525pubmed:dateCreated1991-12-3lld:pubmed
pubmed-article:1945525pubmed:abstractTextLysozyme secretion from macrophages of Schistosoma mansoni-infected mice was time dependent, rising significantly from the 8th week post-infection, the macrophages thereafter exhibiting very high levels (greater than 90%) of schistosomulicidal activity. Despite the ability of lysozyme to kill schistosomula in vitro, the concentrations required for such killing were several hundred-fold to several thousand-fold higher than those detected in the supernatants from infected-mice macrophages cultured with or without schistosomula. An in vitro lysozyme inhibitor, N,N,N-triacetyl chitobiose, did not abrogate the cytotoxic ability of macrophages from schistosome-infected mice, but an inhibitor of arginine-dependent cytotoxicity, NG-monomethyl arginine, markedly inhibited schistosomulicidal activity. Evidently, concentrations of ambient lysozyme from macrophage cultures are too low to affect schistosomula in culture, while the main schistosomulicidal pathway in vitro seems to be arginine dependent.lld:pubmed
pubmed-article:1945525pubmed:languageenglld:pubmed
pubmed-article:1945525pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1945525pubmed:citationSubsetIMlld:pubmed
pubmed-article:1945525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1945525pubmed:statusMEDLINElld:pubmed
pubmed-article:1945525pubmed:monthAuglld:pubmed
pubmed-article:1945525pubmed:issn0031-1820lld:pubmed
pubmed-article:1945525pubmed:authorpubmed-author:GoldDDlld:pubmed
pubmed-article:1945525pubmed:authorpubmed-author:LengyJJlld:pubmed
pubmed-article:1945525pubmed:authorpubmed-author:FlescherEElld:pubmed
pubmed-article:1945525pubmed:authorpubmed-author:KeisariYYlld:pubmed
pubmed-article:1945525pubmed:issnTypePrintlld:pubmed
pubmed-article:1945525pubmed:volume103 Pt 1lld:pubmed
pubmed-article:1945525pubmed:ownerNLMlld:pubmed
pubmed-article:1945525pubmed:authorsCompleteYlld:pubmed
pubmed-article:1945525pubmed:pagination61-4lld:pubmed
pubmed-article:1945525pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:1945525pubmed:meshHeadingpubmed-meshheading:1945525-...lld:pubmed
pubmed-article:1945525pubmed:meshHeadingpubmed-meshheading:1945525-...lld:pubmed
pubmed-article:1945525pubmed:meshHeadingpubmed-meshheading:1945525-...lld:pubmed
pubmed-article:1945525pubmed:meshHeadingpubmed-meshheading:1945525-...lld:pubmed
pubmed-article:1945525pubmed:meshHeadingpubmed-meshheading:1945525-...lld:pubmed
pubmed-article:1945525pubmed:meshHeadingpubmed-meshheading:1945525-...lld:pubmed
pubmed-article:1945525pubmed:meshHeadingpubmed-meshheading:1945525-...lld:pubmed
pubmed-article:1945525pubmed:meshHeadingpubmed-meshheading:1945525-...lld:pubmed
pubmed-article:1945525pubmed:year1991lld:pubmed
pubmed-article:1945525pubmed:articleTitleOn the possible schistosomulicidal effect of macrophage-derived lysozyme.lld:pubmed
pubmed-article:1945525pubmed:affiliationDepartment of Medicine, University of Texas Health Science Center, San Antonio 78284.lld:pubmed
pubmed-article:1945525pubmed:publicationTypeJournal Articlelld:pubmed